Literature DB >> 23066652

Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea.

Min Soo Kim1, Nayoung Kim, Sung Eun Kim, Hyun Jin Jo, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Jung Mogg Kim, Hyun Chae Jung.   

Abstract

BACKGROUND: The reinfection rate of Helicobacter pylori has been reported to be low in developed countries but high in developing countries. The aim of this study is to evaluate the long-term reinfection rate of H. pylori and to investigate its associated risk factors in South Korea.
METHODS: During 2003-2010, H. pylori-positive 970 patients received standard proton pump inhibitor (PPI)-based triple eradication therapy, and follow-up H. pylori tests were performed with (13) C urea breath test or invasive tests (Giemsa histology, CLO test, and culture) 4 weeks after completion of treatment. A total of 331 patients who were maintained an H. pylori-eradicated state at 1 year after eradication were divided into two groups according to reinfection. For the evaluation of risk factors of reinfection, gender, age, smoking, alcohol, income, education, gastrointestinal symptoms, clinical diagnosis, histologic atrophic gastritis or intestinal metaplasia, and clarithromycin resistance were analyzed.
RESULTS: The follow-up period was 18-95 months (mean: 37.1 months), and H. pylori reappeared in 36 of 331 patients (10.9%), resulting in the annual reinfection rate of 3.51% per year. Multivariate analysis showed that male gender (HR 2.28; 95% CI, 1.05-5.00, p = .037) and low monthly family income (≤5000$ vs >5000$) (HR 3.54; 95% CI, 1.08-11.67, p = .038) were associated with H. pylori reinfection.
CONCLUSION: This long-term reinfection rate of H. pylori stayed rather low (3.51% per year), and male and low income determined the reinfection, factors already known to be important for H. pylori infection.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066652     DOI: 10.1111/hel.12018

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  18 in total

1.  High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.

Authors:  Laimas Jonaitis; Gediminas Kiudelis; Paulius Slepavicius; Limas Kupcinskas
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.

Authors:  Yan-Qiang Huang; Gan-Rong Huang; Ming-Hui Wu; Hua-Ying Tang; Zan-Song Huang; Xi-Han Zhou; Wen-Qiang Yu; Jian-Wei Su; Xiao-Qiang Mo; Bing-Pu Chen; Li-Juan Zhao; Xiao-Feng Huang; Hong-Yu Wei; Lian-Deng Wei
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey.

Authors:  Murat Erkut; Doğan Yusuf Uzun; Neşe Kaklıkkaya; Sami Fidan; Yaşar Yoğun; Arif Mansur Coşar; Esma Akyıldız; Murat Topbaş; Orhan Özgür; Mehmet Arslan
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

Review 4.  Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.

Authors:  Sun-Young Lee
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

5.  Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska.

Authors:  M G Bruce; D L Bruden; J M Morris; A L Reasonover; F Sacco; D Hurlburt; T W Hennessy; J Gove; A Parkinson; G Sahagun; P Davis; J Klejka; B J McMahon
Journal:  Epidemiol Infect       Date:  2014-07-28       Impact factor: 4.434

6.  Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.

Authors:  Min Soo Kim; Nayoung Kim; Sung Eun Kim; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Dong Ho Lee
Journal:  BMC Gastroenterol       Date:  2013-09-19       Impact factor: 3.067

7.  Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?

Authors:  Halil Rakici; Remzi Adnan Akdogan; Teslime Ayaz; Recep Bedir
Journal:  Gastroenterol Res Pract       Date:  2015-03-15       Impact factor: 2.260

8.  The diagnostic validity of the (13)c-urea breath test in the gastrectomized patients: single tertiary center retrospective cohort study.

Authors:  Yong Hwan Kwon; Nayoung Kim; Ju Yup Lee; Yoon Jin Choi; Kichul Yoon; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2014-12

9.  Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis.

Authors:  Beom Jin Kim; Hyun-Soo Kim; Hyun Joo Song; Il-Kwun Chung; Gwang Ha Kim; Byung-Wook Kim; Ki-Nam Shim; Seong Woo Jeon; Yun Jin Jung; Chang-Hun Yang; Ji Hyun Kim; Tae Ho Kim; Sang Gyun Kim; Woon Geon Shin; Sun Moon Kim; Sok Won Han; Jun Haeng Lee; Kyung Ho Kim; Sue K Park; Byung-Joo Park; Joongyub Lee; Jae G Kim
Journal:  J Korean Med Sci       Date:  2016-05-16       Impact factor: 2.153

10.  Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy.

Authors:  Sung Eun Kim; Moo In Park; Seun Ja Park; Won Moon; Youn Jung Choi; Ji Hyun Cheon; Hye Jung Kwon; Ki Hwan Ku; Chang Hun Yoo; Jae Hyun Kim; Gyu Won Lee; Sung Eun Song
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.